Literature DB >> 18645206

Muscle protein alterations in LGMD2I patients with different mutations in the Fukutin-related protein gene.

Lydia U Yamamoto1, Fernando J Velloso, Bruno L Lima, Luciana L Q Fogaça, Flávia de Paula, Natássia M Vieira, Mayana Zatz, Mariz Vainzof.   

Abstract

Fukutin-related protein (FKRP) is a protein involved in the glycosylation of cell surface molecules. Pathogenic mutations in the FKRP gene cause both the more severe congenital muscular dystrophy Type 1C and the milder Limb-Girdle Type 2I form (LGMD2I). Here we report muscle histological alterations and the analysis of 11 muscle proteins: dystrophin, four sarcoglycans, calpain 3, dysferlin, telethonin, collagen VI, alpha-DG, and alpha2-laminin, in muscle biopsies from 13 unrelated LGMD2I patients with 10 different FKRP mutations. In all, a typical dystrophic pattern was observed. In eight patients, a high frequency of rimmed vacuoles was also found. A variable degree of alpha2-laminin deficiency was detected in 12 patients through immunofluorescence analysis, and 10 patients presented alpha-DG deficiency on sarcolemmal membranes. Additionally, through Western blot analysis, deficiency of calpain 3 and dystrophin bands was found in four and two patients, respectively. All the remaining proteins showed a similar pattern to normal controls. These results suggest that, in our population of LGMD2I patients, different mutations in the FKRP gene are associated with several secondary muscle protein reductions, and the deficiencies of alpha2-laminin and alpha-DG on sections are prevalent, independently of mutation type or clinical severity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645206      PMCID: PMC2569900          DOI: 10.1369/jhc.2008.951772

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  29 in total

1.  68th ENMC international workshop (5th international workshop): On congenital muscular dystrophy, 9-11 April 1999, Naarden, The Netherlands.

Authors:  V Dubowitz
Journal:  Neuromuscul Disord       Date:  1999-10       Impact factor: 4.296

2.  The limb-girdle muscular dystrophies: genetic and phenotypic definition of a disputed entity.

Authors:  Matthew P Wicklund; David Hilton-Jones
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

Review 3.  Glycosylation defects in inherited muscle disease.

Authors:  J E Hewitt; P K Grewal
Journal:  Cell Mol Life Sci       Date:  2003-02       Impact factor: 9.261

4.  The phenotype of limb-girdle muscular dystrophy type 2I.

Authors:  M Poppe; L Cree; J Bourke; M Eagle; L V B Anderson; D Birchall; M Brockington; M Buddles; M Busby; F Muntoni; A Wills; K Bushby
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

Review 5.  Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.

Authors:  Paul T Martin
Journal:  Glycobiology       Date:  2003-05-07       Impact factor: 4.313

Review 6.  Glycosylation defects: a new mechanism for muscular dystrophy?

Authors:  Prabhjit K Grewal; Jane E Hewitt
Journal:  Hum Mol Genet       Date:  2003-08-12       Impact factor: 6.150

7.  Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.

Authors:  Susan C Brown; Silvia Torelli; Martin Brockington; Yeliz Yuva; Cecilia Jimenez; Lucy Feng; Louise Anderson; Isabella Ugo; Stephan Kroger; Kate Bushby; Thomas Voit; Caroline Sewry; Francesco Muntoni
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

8.  FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts.

Authors:  H Topaloglu; M Brockington; Y Yuva; B Talim; G Haliloglu; D Blake; S Torelli; S C Brown; F Muntoni
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

Review 9.  The role of defective glycosylation in congenital muscular dystrophy.

Authors:  Harry Schachter; Jiri Vajsar; Wenli Zhang
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

10.  Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum.

Authors:  Flavia de Paula; Natássia Vieira; Alessandra Starling; Lydia Uraco Yamamoto; Bruno Lima; Rita de Cássia Pavanello; Mariz Vainzof; Vincenzo Nigro; Mayana Zatz
Journal:  Eur J Hum Genet       Date:  2003-12       Impact factor: 4.246

View more
  8 in total

1.  Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].

Authors:  Chi-Hsien Wang; Yiumo Michael Chan; Ru-Hang Tang; Bin Xiao; Peijuan Lu; Elizabeth Keramaris-Vrantsis; Hui Zheng; Chunping Qiao; Jiangang Jiang; Juan Li; Hsin-I Ma; Qilong Lu; Xiao Xiao
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  Diagnostic muscle biopsies in the era of genetics: the added value of myopathology in a selection of limb-girdle muscular dystrophy patients.

Authors:  Boel De Paepe; Elise Velghe; Linnea Salminen; Balint Toth; Pieter Olivier; Jan L De Bleecker
Journal:  Acta Neurol Belg       Date:  2021-01-05       Impact factor: 2.396

Review 3.  Fukutin-Related Protein: From Pathology to Treatments.

Authors:  Carolina Ortiz-Cordero; Karim Azzag; Rita C R Perlingeiro
Journal:  Trends Cell Biol       Date:  2020-12-01       Impact factor: 20.808

4.  Clinical, genetic, and pathologic characterization of FKRP Mexican founder mutation c.1387A>G.

Authors:  Angela J Lee; Karra A Jones; Russell J Butterfield; Mary O Cox; Chamindra G Konersman; Carla Grosmann; Jose E Abdenur; Monica Boyer; Brent Beson; Ching Wang; James J Dowling; Melissa A Gibbons; Alison Ballard; Joanne S Janas; Robert T Leshner; Sandra Donkervoort; Carsten G Bönnemann; Denise M Malicki; Robert B Weiss; Steven A Moore; Katherine D Mathews
Journal:  Neurol Genet       Date:  2019-03-01

5.  The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice.

Authors:  Charlotte Whitmore; Marta Fernandez-Fuente; Helen Booler; Callum Parr; Manoli Kavishwar; Attia Ashraf; Erica Lacey; Jihee Kim; Rebecca Terry; Mark R Ackroyd; Kim E Wells; Francesco Muntoni; Dominic J Wells; Susan C Brown
Journal:  Hum Mol Genet       Date:  2013-11-13       Impact factor: 6.150

6.  Theragnosis for Duchenne Muscular Dystrophy.

Authors:  Leonela Luce; Micaela Carcione; Chiara Mazzanti; Paula I Buonfiglio; Viviana Dalamón; Lilia Mesa; Alberto Dubrovsky; José Corderí; Florencia Giliberto
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

7.  Neuromuscular disorders: genes, genetic counseling and therapeutic trials.

Authors:  Mayana Zatz; Maria Rita Passos-Bueno; Mariz Vainzof
Journal:  Genet Mol Biol       Date:  2016 Jul-Sep       Impact factor: 1.771

8.  Titin mutation segregates with hereditary myopathy with early respiratory failure.

Authors:  Gerald Pfeffer; Hannah R Elliott; Helen Griffin; Rita Barresi; James Miller; Julie Marsh; Anni Evilä; Anna Vihola; Peter Hackman; Volker Straub; David J Dick; Rita Horvath; Mauro Santibanez-Koref; Bjarne Udd; Patrick F Chinnery
Journal:  Brain       Date:  2012-05-09       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.